Cargando…
β-Hydroxybutyrate Mitigated Heart Failure with Preserved Ejection Fraction by Increasing Treg Cells via Nox2/GSK-3β
BACKGROUND: This study was designed to investigate the cardioprotective role of β-hydroxybutyrate (BHB) in heart failure with preserved ejection fraction (HFpEF) and the underlying mechanism. METHODS: A two-hit model with a high-fat diet (HFD) and N(ω)-nitrol-arginine methyl ester (L-NAME) was used...
Autores principales: | Liao, Shengen, Tang, Yuan, Yue, Xin, Gao, Rongrong, Yao, Wenming, Zhou, Yanli, Zhang, Haifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453303/ https://www.ncbi.nlm.nih.gov/pubmed/34557014 http://dx.doi.org/10.2147/JIR.S331320 |
Ejemplares similares
-
Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate–activated Citrate Synthase
por: Zhang, Xinxin, et al.
Publicado: (2023) -
Cardiac Rehabilitation Increases SIRT1 Activity and β-Hydroxybutyrate Levels and Decreases Oxidative Stress in Patients with HF with Preserved Ejection Fraction
por: Corbi, Graziamaria, et al.
Publicado: (2019) -
Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction
por: Ma, Sai, et al.
Publicado: (2022) -
Circulating neuregulin1‐β in heart failure with preserved and reduced left ventricular ejection fraction
por: Hage, Camilla, et al.
Publicado: (2020) -
Cardiac Adrenergic Activation in Heart Failure With Preserved Ejection Fraction: A Role for β-Blockade?
por: Bristow, Michael R., et al.
Publicado: (2022)